SUDEEPPHRM Stock Chart & Stats
₹866.45
₹9.95(1.16%)
―
--
Day’s Range― - ―
52-Week Range₹524.95 - ₹885.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)515.54K
Market Cap
₹97.86B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)56.4
Beta0.61
Next Earnings
Dec 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.40
Shares Outstanding112,948,620
10 Day Avg. Volume50,019
30 Day Avg. Volume515,536
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.1
Revenue Forecast (FY)₹7.40B
Sudeep Pharma Limited News
SUDEEPPHRM FAQ
What was Sudeep Pharma Limited’s price range in the past 12 months?
Sudeep Pharma Limited lowest stock price was ₹524.95 and its highest was ₹885.00 in the past 12 months.
What is Sudeep Pharma Limited’s market cap?
Sudeep Pharma Limited’s market cap is ₹97.86B.
When is Sudeep Pharma Limited’s upcoming earnings report date?
Sudeep Pharma Limited’s upcoming earnings report date is Dec 18, 2026 which is in 165 days.
How were Sudeep Pharma Limited’s earnings last quarter?
Sudeep Pharma Limited released its earnings results on May 21, 2026. The company reported ₹4.4 earnings per share for the quarter, beating the consensus estimate of ₹4.35 by ₹0.05.
Is Sudeep Pharma Limited overvalued?
According to Wall Street analysts Sudeep Pharma Limited’s price is currently Undervalued.
Does Sudeep Pharma Limited pay dividends?
Sudeep Pharma Limited does not currently pay dividends.
What is Sudeep Pharma Limited’s EPS estimate?
Sudeep Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sudeep Pharma Limited have?
Sudeep Pharma Limited has 112,948,620 shares outstanding.
What happened to Sudeep Pharma Limited’s price movement after its last earnings report?
Sudeep Pharma Limited reported an EPS of ₹4.4 in its last earnings report, beating expectations of ₹4.35. Following the earnings report the stock price went up 2.777%.
Which hedge fund is a major shareholder of Sudeep Pharma Limited?
Currently, no hedge funds are holding shares in IN:SUDEEPPHRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sudeep Pharma Limited
Established in 1989 and headquartered in Vadodara, India, Sudeep Pharma Limited specializes in the manufacturing and distribution of excipients and unique ingredients. The company serves the pharmaceutical, food, and nutrition sectors, with a market reach extending across the United States, Europe, the United Kingdom, and Latin America. Its product range includes essential mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, which are vital for a variety of health-focused applications. Sudeep Pharma also provides calcium carbonate, utilized as an active pharmaceutical ingredient in diverse therapeutic contexts. Furthermore, the company develops and supplies advanced nutrient formulations, including micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends. These innovative solutions are designed for applications in functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food products. Beyond production, Sudeep Pharma's extensive operations encompass the development, trade, import, export, and processing of a broad spectrum of pharmaceuticals, nutraceuticals, food ingredients, and vitamin/mineral blends for human and animal nutrition, alongside other chemical and healthcare products.
Balaxi Pharmaceuticals Limited
―
Bal Pharma Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Lasa Supergenerics Ltd.
―
Parenteral Drugs (India) Limited
―



